Nu Skin Enterprises (NUS) Downgraded by Zacks Investment Research to “Sell”
Zacks Investment Research lowered shares of Nu Skin Enterprises (NYSE:NUS) from a hold rating to a sell rating in a research report report published on Tuesday morning.
According to Zacks, “Nu Skin’s shares have underperformed the industry in the past three months, thanks to dismal gross margins and adverse impacts from currency fluctuations. In fact, the company’s gross margin has been slipping since the past several quarters. This emerges as a considerable threat to profitability. Moreover, the company’s bottom-line in the third-quarter was hurt by foreign currency translation losses of almost 7 cents. Management expects currency translations to dent earnings in 2018. On the bright side, Nu Skin has been steadily gaining from expanding sales leaders and customers. Notably, these upsides aided third-quarter 2018 results, marking its fourth consecutive period of year-on-year top- and bottom-line increases. The company plans to further empower sales leaders through improved training and technological enhancements. Further, it relies on social media as well as product and marketing programs to widen customer reach.”
A number of other analysts also recently commented on the stock. Bank of America reiterated an underperform rating and issued a $65.00 target price (down from $75.00) on shares of Nu Skin Enterprises in a report on Thursday, December 6th. Tigress Financial reiterated a buy rating on shares of Nu Skin Enterprises in a report on Wednesday, November 21st. Citigroup set a $88.00 target price on shares of Nu Skin Enterprises and gave the stock a buy rating in a report on Thursday, November 8th. Jefferies Financial Group reiterated a buy rating and issued a $92.00 target price on shares of Nu Skin Enterprises in a report on Thursday, November 8th. Finally, DA Davidson began coverage on shares of Nu Skin Enterprises in a report on Tuesday, October 9th. They issued a buy rating and a $92.00 target price on the stock. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and six have issued a buy rating to the stock. Nu Skin Enterprises has an average rating of Hold and a consensus target price of $83.63.
Nu Skin Enterprises (NYSE:NUS) last released its earnings results on Wednesday, November 7th. The company reported $0.94 EPS for the quarter, missing analysts’ consensus estimates of $0.96 by ($0.02). Nu Skin Enterprises had a return on equity of 27.50% and a net margin of 5.93%. The business had revenue of $675.31 million during the quarter, compared to the consensus estimate of $664.99 million. During the same quarter in the previous year, the firm earned $0.76 earnings per share. The firm’s revenue for the quarter was up 19.8% compared to the same quarter last year. On average, research analysts expect that Nu Skin Enterprises will post 3.51 EPS for the current fiscal year.
In other news, General Counsel D Matthew Dorny sold 2,500 shares of the business’s stock in a transaction that occurred on Monday, December 3rd. The shares were sold at an average price of $67.53, for a total transaction of $168,825.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders have sold 6,250 shares of company stock worth $407,925 in the last 90 days. 3.00% of the stock is owned by company insiders.
Hedge funds have recently added to or reduced their stakes in the company. Harvest Fund Management Co. Ltd raised its holdings in shares of Nu Skin Enterprises by 162.9% during the third quarter. Harvest Fund Management Co. Ltd now owns 1,291 shares of the company’s stock valued at $106,000 after acquiring an additional 800 shares during the period. Global X Management Co LLC grew its position in Nu Skin Enterprises by 141.9% during the second quarter. Global X Management Co LLC now owns 1,732 shares of the company’s stock valued at $135,000 after purchasing an additional 1,016 shares in the last quarter. Ffcm LLC grew its position in Nu Skin Enterprises by 181.9% during the third quarter. Ffcm LLC now owns 1,911 shares of the company’s stock valued at $177,000 after purchasing an additional 1,233 shares in the last quarter. First Hawaiian Bank purchased a new position in Nu Skin Enterprises during the third quarter valued at approximately $165,000. Finally, Advisors Asset Management Inc. grew its position in Nu Skin Enterprises by 151.9% during the third quarter. Advisors Asset Management Inc. now owns 2,345 shares of the company’s stock valued at $193,000 after purchasing an additional 1,414 shares in the last quarter. Institutional investors and hedge funds own 74.57% of the company’s stock.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.
See Also: Net Income
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.